AGP Executive Report
Last update: 8 hours agoPrimary Care Breakthrough: A Dutch multicenter trial found nurse-led protocolled care significantly improved asthma control in children aged 6–12, with higher C-ACT scores at 18 months and fewer uncontrolled cases than usual care. Cancer Follow-up Savings: Amsterdam UMC reports that patients with high-risk bowel polyps can safely wait five years for their first follow-up instead of three, with very low colorectal cancer rates and no deaths within five years—potentially cutting tens of thousands of invasive exams annually. Blood Safety Update: Sanquin will start testing all blood donations for West Nile virus in nine provinces after a fourth transfusion-related death; infections have risen to 28, with risk screening focused on affected regions. Care Access for Visitors: Australia’s reciprocal health agreements include the Netherlands, offering eligible visitors access to Medicare-subsidized medically necessary hospital care (public patient/inpatient/outpatient), though elective procedures are excluded. Clinical Decision Debate: A Netherlands study (APACHE-AF) on anticoagulation after intracerebral hemorrhage in atrial fibrillation found no clear benefit on nonfatal stroke/vascular death, but more bleeding with apixaban—fueling ongoing “anticoagulation conundrum” discussions.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.